Abstract
MK-927 is a novel topical carbonic anhydrase inhibitor (CAI). We present the first single-dose clinical trial of MK-927 in 24 patients with bilateral primary open-angle glaucoma or ocular hypertension. This investigation was conducted as a two-centre, double-masked, randomised, placebo controlled study. Patients received one drop of 2% MK-927 in one eye and placebo in the other eye. Modified diurnal intraocular pressure (IOP) curves were performed before the study and on one treatment day. A single dose of 2% MK-927 induced a peak mean IOP decrease of 10.5 mmHg at 4.5 hours postdose. With compensation for diurnal variation, as determined by the prestudy diurnal pressure curve, the net peak mean reduction of IOP caused by MK-927 was 7.5 mmHg versus a corresponding net change of 1.4 mmHg in the contralateral placebo treated eye. Thus a single dose of MK-927 gave a clinically significant IOP reduction in patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BECKER B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. Am J Ophthalmol. 1954 Jan;37(1):13–15. doi: 10.1016/0002-9394(54)92027-9. [DOI] [PubMed] [Google Scholar]
- FOSS R. H. Local application of diamox; an experimental study of its effect on the intraocular pressure. Am J Ophthalmol. 1955 Mar;39(3):336–337. [PubMed] [Google Scholar]
- Lewis R. A., Schoenwald R. D., Barfknecht C. F., Phelps C. D. Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension. Arch Ophthalmol. 1986 Jun;104(6):842–844. doi: 10.1001/archopht.1986.01050180076033. [DOI] [PubMed] [Google Scholar]
- Lippa E. A., von Denffer H. A., Hofmann H. M., Brunner-Ferber F. L. Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1988 Dec;106(12):1694–1696. doi: 10.1001/archopht.1988.01060140866029. [DOI] [PubMed] [Google Scholar]
- Ponticello G. S., Freedman M. B., Habecker C. N., Lyle P. A., Schwam H., Varga S. L., Christy M. E., Randall W. C., Baldwin J. J. Thienothiopyran-2-sulfonamides: a novel class of water-soluble carbonic anhydrase inhibitors. J Med Chem. 1987 Apr;30(4):591–597. doi: 10.1021/jm00387a002. [DOI] [PubMed] [Google Scholar]
- Werner E. B., Gerber D. S., Yoder Y. J. Effect of a topical carbonic anhydrase inhibitor, 6-hydroxybenzo[b]thiophene-2-sulfonamide, on intraocular pressure in normotensive subjects. Can J Ophthalmol. 1987 Oct;22(6):316–319. [PubMed] [Google Scholar]